111 (YI) Issuance of Debt : $0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is 111 Issuance of Debt?

111's Issuance of Debt for the three months ended in Dec. 2023 was $0 Mil.

111's Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2023 was $0 Mil.

111 Issuance of Debt Historical Data

The historical data trend for 111's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

111 Issuance of Debt Chart

111 Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Issuance of Debt

Get a 7-Day Free Trial

21.52

60.98

63.88

113.05

111 Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Issuance of Debt	Get a 7-Day Free Trial															-	-	-	-	-

111 Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

111 Issuance of Debt Related Terms

Thank you for viewing the detailed overview of 111's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

111 (YI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » 111 Inc (NAS:YI) » Definitions » Issuance of Debt

Comparable Companies

Traded in Other Exchanges

811A:Germany 811A:Germany

Address

No.295 ZuChongZhi Road, 3rd-5th Floors, Pudong New Area, Shanghai, CHN, 201203

Website

https://ir.111.com.cn

111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.